ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares

NEXT STORY
NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHS
PREV STORY
DAWOODI BOHRAS OFFER MUCH-NEEDED SUPPORT TO THE ELDERLY
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers

author_avatar
NASDAQ Market News

Dupixent® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months

author_avatar
NASDAQ Market News

Aceragen Announces Acquisition of Arrevus, Expands Late-Stage Rare Disease Pipeline

author_avatar
NASDAQ Market News